Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-21-000327
Filing Date
2021-01-06
Accepted
2021-01-06 07:33:12
Documents
5
Period of Report
2021-01-06

Document Format Files

Seq Description Document Type Size
1 6-K sln-6k_20210106.htm 6-K 28730
2 EX-99.1 sln-ex991_7.htm EX-99.1 17759
3 EX-99.2 sln-ex992_6.htm EX-99.2 24304
4 GRAPHIC gvw0sqim0cg5000001.jpg GRAPHIC 4565
5 GRAPHIC gspwlsoy1hcc000001.jpg GRAPHIC 4565
  Complete submission text file 0001564590-21-000327.txt   84635
Mailing Address 72 HAMMERSMITH ROAD LONDON X0 W14 8TH
Business Address 72 HAMMERSMITH ROAD LONDON X0 W14 8TH 44-0-20-3457 6900
Silence Therapeutics plc (Filer) CIK: 0001479615 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0
Type: 6-K | Act: 34 | File No.: 001-39487 | Film No.: 21509003
SIC: 2834 Pharmaceutical Preparations